First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

Clinical trial NCT05156866 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05156866
Sponsor: TORL Biotherapeutics, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Gastric Cancer Pancreas Cancer Gastroesophageal Junction Adenocarcinoma

Start date: 2022-02-02
Primary completion: 2026-06-15
Enrollment: 163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.